Category: Include on Menu
-
Neumora Ends Depression Drug Programme and Announces Workforce Reduction (NMRA)
Neumora Therapeutics (NASDAQ:NMRA) said on Monday that it will halt development of its experimental depression treatment navacaprant after two Phase III clinical studies failed to meet their primary efficacy goals. The drug candidate had been under evaluation as a potential treatment for patients suffering from major depressive disorder. Late-Stage Trial Setbacks Prompt Strategic Review The…
-
Payoneer Shares Climb After Nuvei Agrees $2.75 Billion Takeover (PAYO)
Payoneer Global Inc. (NASDAQ:PAYO) shares advanced 3.4% in premarket trading on Monday after Nuvei revealed plans to acquire the payments platform in an all-cash transaction valued at approximately $2.75 billion. Under the agreement, Nuvei will purchase all outstanding Payoneer shares for $7.40 per share in cash. The transaction has received unanimous approval from the boards…
-
U.S.-Iran Agreement Set to Lift Wall Street at the Open: Dow Jones, S&P, Nasdaq, Futures
U.S. stock futures pointed to a strong start for trading on Monday, with investors expected to build on the gains recorded during the previous two sessions following news that Washington and Tehran have agreed to end a conflict that has lasted for more than three months. The positive sentiment comes as markets assess the potential…
-
Travel Sector Rallies as Iran Agreement Sends Oil Prices Lower
Airline and cruise company shares posted strong gains on Monday after the United States and Iran announced a preliminary agreement aimed at ending the conflict between the two nations and reopening the Strait of Hormuz. Investors welcomed the development, viewing it as a potential catalyst for lower energy costs and improved profitability across the travel…
-
Advancing a flagship project in Ireland with recent drilling returning multi-mineral intercepts
What if one of the most exciting silver discoveries in Europe isn’t a traditional silver jurisdiction at all? Hello, I’m Ricki Lee and this is The Capital Compass. Today we’re checking back in with Group Eleven Resources (TSXV:ZNG) (USOTC:GRLVF), a company advancing its flagship project in Ireland where recent drilling continues to return, impressive intercepts…
-
Five Key Market Themes Investors Will Be Watching This Week
A preliminary peace agreement between the United States and Iran has emerged as the dominant market story at the start of the week, with investors assessing the implications for energy markets, inflation and central bank policy. Attention is also focused on a series of interest-rate decisions from major central banks, the post-IPO performance of SpaceX…
-
Iran Agreement Could Ease Inflation Concerns Ahead of Warsh’s First Fed Meeting
A potential agreement with Iran may help reduce inflationary pressures in the United States as Kevin Warsh prepares to chair his first meeting of the Federal Open Market Committee (FOMC), according to analysts at Canaccord. The broker believes that easing tensions in the Middle East and lower energy prices could provide some support to policymakers…
-
Traws Pharma Shares Slide After UK Regulator Postpones Influenza Study
Traws Pharma (NASDAQ:TRAW) shares fell sharply in premarket trading on Monday after the company revealed that UK regulators had delayed a planned mid-stage clinical trial for its influenza treatment candidate. The setback adds to previous regulatory challenges facing the programme and prompted investors to reassess the drug’s development timeline. MHRA Issues Negative Assessment Late on…
-
Tesla Faces Scrutiny Over FSD Safety Claims Submitted to European Regulators
Tesla (NASDAQ:TSLA) provided self-generated safety data to regulators in several European countries as part of its effort to secure approval for its Full Self-Driving (FSD) system, but independent road-safety experts have questioned the validity of the figures, arguing that they may present an overly favourable view of the technology’s safety performance. The issue comes as…
-
Ferrari Shares Rally After Morgan Stanley Upgrade on Valuation Opportunity
Morgan Stanley upgraded Ferrari (NYSE:RACE) to Overweight from Equal Weight on Monday, arguing that the luxury carmaker’s recent share price weakness has become disconnected from the underlying fundamentals of the business. The investment bank also increased its price target to €380 from €330, suggesting potential upside of around 24% from Friday’s closing level. Shares in…